yenyap
2022-02-12

$Pfizer(PFE) last year sales was $80 billion price hit to $60, this year forecast sales $100 billion or more thus the price will hit $70 to $75 with China Paxlovid 's purchase. HOLD tight 

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
  • CrystalRose
    ·2022-02-12
    Longs buy and all more at this level, wallstreet is just playing mind games with u. Starting next Monday they will pump the SP up to $60 once the weak hand leaves
    Reply
    Report
  • AfraSimon
    ·2022-02-12
    你的钱在安全的手中，不要卖掉你的辉瑞股票，而是买更多的，积累
    Reply
    Report
    Fold Replies
    • CrystalRose: 
      伙计们在这个水平上坚持并购买更多。这只是华尔街的游戏，以吓跑弱小的投资者
      2022-02-12
      Reply
      Report
    • BorisBack: 
      我没有卖出一只股票，也没有去任何地方，我每周都在买辉瑞的股票。
      2022-02-12
      Reply
      Report
  • BorisBack
    ·2022-02-12
    Nice rebound. I guess people are looking for the safety of aprox. $100 billion in confirmed revenues.
    Reply
    Report
  • CatherineGunter
    ·2022-02-12
    Do you want to ride these shares back down to $30.00? Time to sell. The juice is clogging people up.
    Reply
    Report
  • BaronLyly
    ·2022-02-12
    Holding well on red market, expect big rebound next week. $80+ by December
    Reply
    Report
  • KittyBruno
    ·2022-02-12
    It is amazing how the shorts always succeed to pull the price PFE down. This must be some sort of a cartel who acts together to make sure it stays down during a certain period.
    Reply
    Report
  • ChristKitto
    ·2022-02-12
    This company really needs a boost to its portfolio of drugs. I would like to see them acquire some up and coming companies such as Intracellular or Cassava Sciences.
    Reply
    Report
  • MyrnaNorth
    ·2022-02-12
    Why’s it going down? I though the MRNA vaccines were safe and effective? Shouldn’t this help the stock price?
    Reply
    Report
  • CyrilDavy
    ·2022-02-12
    Bottom is in guys, load up the rocketship for a pump next week! DO NOT sell your shares just when the rocketship is about to take off.
    Reply
    Report
  • EmilyMark
    ·2022-02-12
    大流行快结束了。辉瑞股票没有理由保持目前的高位。未来的销售仍然暗淡。
    Reply
    Report
  • littlesweetie
    ·2022-02-12
    They will soon be talking of 2023 sales.....and you know where Pfizer sales will be. Not very good. Might end up in the 20's
    Reply
    Report
  • LeilaLynch
    ·2022-02-12
    PFE did the right thing today by delaying.... Should always put science ahead of profits. Will work out fine in the end.
    Reply
    Report
  • MatthewWalter
    ·2022-02-12
    40 or 60 next? Thumbs down if u think Pfe heading to 40s next. Thumbs up if u think Pfe heading to 60s next
    Reply
    Report
  • KittyBruno
    ·2022-02-12
    I'm holding on to my stocks. The vaccine will get approved on soon.😀😀😀😀😀😂😂😂
    Reply
    Report